Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Jeffrey Wang, Jacqueline Wang, Elyse Lopez, Hui Guo, Hui Zhang, Yang Liu, Zhihong Chen, Shengjian Huang, Shouhao Zhou, Angela Leeming, R. J. Zhang, Dayoung Jung, Hannah Shi, Hadley Grundman, Darian Doakes, Kathleen Cui, Changying Jiang, Makhdum Ahmed, Krystle Nomie, Bingliang FangMichael Wang, Yixin Yao, Liang Zhang

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article number95
JournalBlood Cancer Journal
Volume9
Issue number12
DOIs
Publication statusPublished - Dec 1 2019

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Wang, J., Wang, J., Lopez, E., Guo, H., Zhang, H., Liu, Y., ... Zhang, L. (2019). Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma. Blood Cancer Journal, 9(12), [95]. https://doi.org/10.1038/s41408-019-0259-8